Creative Medical Technology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary

Creative Medical Technology Holdings

07/08/2026 22:52

Creative Medical Technology Holdings Inc CELZ.OQ reported a quarterly adjusted loss of 41 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -48 cents.  The lone analyst forecast for the quarter was for a loss of 39 cents per share. 
Reported revenue was zero​; analysts expected zero. 
Creative Medical Technology Holdings Inc's reported EPS for the quarter was a loss of 41 cents​.
The company reported a quarterly loss of $1.51 million.
Creative Medical Technology Holdings Inc shares had fallen by 20.7% this quarter and lost 41.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 5.4% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for Creative Medical Technology Holdings Inc is $20.00, about 94.3% above its last closing price of $1.15
This summary was machine generated from LSEG data August 7 at 09:52 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.39
-0.41
Missed
Mar. 31 2026 
-0.39
-0.38
Beat
Dec. 31 2025 
-0.37
Sep. 30 2025 
-0.48
-0.48
Met